Truist Financial Corp Has $19.11 Million Position in CME Group Inc. $CME

Truist Financial Corp grew its holdings in CME Group Inc. (NASDAQ:CME) by 8.9% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 70,712 shares of the financial services provider’s stock after buying an additional 5,773 shares during the quarter. Truist Financial Corp’s holdings in CME Group were worth $19,106,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of CME. Caldwell Trust Co boosted its holdings in CME Group by 116.3% in the third quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 50 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new position in shares of CME Group during the third quarter worth about $27,000. Financial Consulate Inc. bought a new position in CME Group in the third quarter valued at $28,000. Sagard Holdings Management Inc. acquired a new stake in shares of CME Group in the 2nd quarter valued at approximately $30,000. Finally, Corundum Trust Company INC bought a new position in CME Group during the third quarter worth $30,000. Institutional investors own 87.75% of the company’s stock.

Insider Activity at CME Group

In other news, CEO Terrence A. Duffy sold 25,000 shares of the firm’s stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the sale, the chief executive officer owned 65,804 shares of the company’s stock, valued at $17,737,468.20. This trade represents a 27.53% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director William R. Shepard acquired 251 shares of the stock in a transaction dated Tuesday, December 30th. The stock was acquired at an average price of $278.37 per share, for a total transaction of $69,870.87. Following the purchase, the director directly owned 258,710 shares in the company, valued at approximately $72,017,102.70. This trade represents a 0.10% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.30% of the stock is currently owned by insiders.

CME Group Stock Performance

CME Group stock opened at $289.06 on Friday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The stock’s 50 day simple moving average is $275.25 and its two-hundred day simple moving average is $272.35. The stock has a market cap of $104.24 billion, a price-to-earnings ratio of 28.01, a PEG ratio of 3.26 and a beta of 0.27. CME Group Inc. has a fifty-two week low of $233.66 and a fifty-two week high of $291.76.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 30th. Investors of record on Friday, December 12th were paid a $1.25 dividend. The ex-dividend date was Friday, December 12th. This represents a $5.00 dividend on an annualized basis and a yield of 1.7%. CME Group’s payout ratio is presently 48.45%.

Analyst Ratings Changes

CME has been the subject of several analyst reports. Rothschild & Co Redburn boosted their target price on shares of CME Group from $297.00 to $300.00 and gave the company a “neutral” rating in a research report on Thursday, November 6th. Argus decreased their price target on shares of CME Group from $308.00 to $295.00 in a research note on Friday, October 31st. Barclays raised their price target on shares of CME Group from $280.00 to $304.00 and gave the company an “equal weight” rating in a research report on Friday, December 12th. Deutsche Bank Aktiengesellschaft raised their price target on shares of CME Group from $310.00 to $318.00 and gave the stock a “buy” rating in a research note on Wednesday, December 17th. Finally, TD Cowen raised shares of CME Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 14th. Nine equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $292.18.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.